For those of us who have invested in Tonix Pharmaceutical Holding Corp (TNXP), it has become painfully clear that the CEO, Seth Lederman, represents a troubling obstacle to the potential growth of the company we love. The management under Lederman has misused our hard-earned investments as a big piggy bank by repeatedly enacting reverse splits of the company stock (r/s). With an astonishing track record of eight r/s, the corporate strategy appears more focused on milking retail investors rather than promoting the company's progress and profitability.

We believe in TNXP and its drug pipeline—we foresee exponential growth. The opportunity for growth is stifled, however, by a CEO and management that lacks the responsibility and vision to propel the company forward. Our faith in the potential of TNXP is unwavering, but our trust in its leadership is faltering.

For the sake of our investments and the future of this remarkable company, we call upon the pertinent authorities and stakeholders to seek and install a leadership team that respects and optimizes our investments rather than exploiting them.

We, the retail investors, are not merely silent shareholders, but crucial components of TNXP's success. Let this petition serve as a declaration of our dissatisfaction and a demand for change. Stand with us—sign this petition to call for the replacement of CEO Seth Lederman and the present management team at TNXP. Together, we are a force to be reckoned with.